Prudential Financial’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $215K | Sell |
5,300
-8,240
| -61% | -$334K | ﹤0.01% | 2189 |
|
|
2025
Q1 | $599K | Sell |
13,540
-259,400
| -95% | -$11.5M | ﹤0.01% | 1760 |
|
|
2024
Q4 | $11.5M | Buy |
272,940
+237,003
| +659% | +$9.97M | 0.02% | 555 |
|
|
2024
Q3 | $2M | Buy |
+35,937
| New | +$2M | ﹤0.01% | 1497 |
|
|
2023
Q4 | – | Sell |
-6,409
| Closed | -$228K | – | 2705 |
|
|
2023
Q3 | $228K | Sell |
6,409
-4,481
| -41% | -$160K | ﹤0.01% | 2350 |
|
|
2023
Q2 | $502K | Buy |
10,890
+4,337
| +66% | +$200K | ﹤0.01% | 2111 |
|
|
2023
Q1 | $263K | Buy |
+6,553
| New | +$263K | ﹤0.01% | 2311 |
|
|
2022
Q4 | – | Sell |
-8,390
| Closed | -$348K | – | 2680 |
|
|
2022
Q3 | $348K | Sell |
8,390
-24,445
| -74% | -$1.01M | ﹤0.01% | 2241 |
|
|
2022
Q2 | $1.96M | Sell |
32,835
-28,100
| -46% | -$1.68M | ﹤0.01% | 1395 |
|
|
2022
Q1 | $4.43M | Buy |
60,935
+55,320
| +985% | +$4.02M | 0.01% | 1039 |
|
|
2021
Q4 | $472K | Sell |
5,615
-15,100
| -73% | -$1.27M | ﹤0.01% | 2221 |
|
|
2021
Q3 | $1.87M | Sell |
20,715
-71,314
| -77% | -$6.43M | ﹤0.01% | 1494 |
|
|
2021
Q2 | $8.78M | Sell |
92,029
-44,419
| -33% | -$4.24M | 0.01% | 813 |
|
|
2021
Q1 | $15.5M | Sell |
136,448
-10,155
| -7% | -$1.16M | 0.02% | 591 |
|
|
2020
Q4 | $20.3M | Buy |
146,603
+7,766
| +6% | +$1.08M | 0.03% | 453 |
|
|
2020
Q3 | $11.4M | Buy |
138,837
+118,158
| +571% | +$9.71M | 0.02% | 603 |
|
|
2020
Q2 | $1.62M | Sell |
20,679
-50,541
| -71% | -$3.95M | ﹤0.01% | 1435 |
|
|
2020
Q1 | $3.17M | Buy |
71,220
+48,970
| +220% | +$2.18M | 0.01% | 1127 |
|
|
2019
Q4 | $950K | Buy |
+22,250
| New | +$950K | ﹤0.01% | 1874 |
|
|
2019
Q3 | – | Sell |
-5,110
| Closed | -$324K | – | 2459 |
|
|
2019
Q2 | $324K | Buy |
5,110
+130
| +3% | +$8.24K | ﹤0.01% | 2202 |
|
|
2019
Q1 | $345K | Buy |
+4,980
| New | +$345K | ﹤0.01% | 2185 |
|
|
2018
Q4 | – | Sell |
-4,380
| Closed | -$334K | – | 2437 |
|
|
2018
Q3 | $334K | Hold |
4,380
| – | – | ﹤0.01% | 2155 |
|
|
2018
Q2 | $337K | Buy |
4,380
+250
| +6% | +$19.2K | ﹤0.01% | 2164 |
|
|
2018
Q1 | $211K | Sell |
4,130
-26,204
| -86% | -$1.34M | ﹤0.01% | 2248 |
|
|
2017
Q4 | $1.41M | Buy |
30,334
+12,594
| +71% | +$584K | ﹤0.01% | 1727 |
|
|
2017
Q3 | $945K | Buy |
17,740
+10,970
| +162% | +$584K | ﹤0.01% | 1855 |
|
|
2017
Q2 | $420K | Buy |
6,770
+3,110
| +85% | +$193K | ﹤0.01% | 2068 |
|
|
2017
Q1 | $248K | Buy |
3,660
+200
| +6% | +$13.6K | ﹤0.01% | 2187 |
|
|
2016
Q4 | $243K | Buy |
3,460
+10
| +0.3% | +$702 | ﹤0.01% | 2202 |
|
|
2016
Q3 | $245K | Buy |
+3,450
| New | +$245K | ﹤0.01% | 2177 |
|
|
2016
Q2 | – | Sell |
-4,724
| Closed | -$299K | – | 2325 |
|
|
2016
Q1 | $299K | Buy |
4,724
+1,574
| +50% | +$99.6K | ﹤0.01% | 2112 |
|
|
2015
Q4 | $353K | Buy |
3,150
+250
| +9% | +$28K | ﹤0.01% | 2046 |
|
|
2015
Q3 | $279K | Buy |
2,900
+360
| +14% | +$34.6K | ﹤0.01% | 2062 |
|
|
2015
Q2 | $260K | Buy |
+2,540
| New | +$260K | ﹤0.01% | 2083 |
|